Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Droplet-based microfluidic synthesis of nanogels for controlled drug delivery: tailoring nanomaterial properties via pneumatically actuated flow-focusing junction.
Giannitelli SM, Limiti E, Mozetic P, Pinelli F, Han X, Abbruzzese F, Basoli F, Del Rio D, Scialla S, Rossi F, Trombetta M, Rosanò L, Gigli G, Zhang ZJ, Mauri E, Rainer A. Giannitelli SM, et al. Among authors: rosano l. Nanoscale. 2022 Aug 11;14(31):11415-11428. doi: 10.1039/d2nr00827k. Nanoscale. 2022. PMID: 35903969
The interaction of β-arrestin1 with talin1 driven by endothelin A receptor as a feature of α5β1 integrin activation in high-grade serous ovarian cancer.
Masi I, Ottavi F, Del Rio D, Caprara V, Vastarelli C, Giannitelli SM, Fianco G, Mozetic P, Buttarelli M, Ferrandina G, Scambia G, Gallo D, Rainer A, Bagnato A, Spadaro F, Rosanò L. Masi I, et al. Among authors: rosano l. Cell Death Dis. 2023 Jan 30;14(1):73. doi: 10.1038/s41419-023-05612-7. Cell Death Dis. 2023. PMID: 36717550 Free PMC article.
HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M, Sandoval P, Bontempi G, Montaldo C, Tomero-Sanz H, de Turris V, Trionfetti F, Pascual-Antón L, Clares-Pedrero I, Battistelli C, Valente S, Zwergel C, Mai A, Rosanò L, Del Pozo MÁ, Sánchez-Álvarez M, Cabañas C, Tripodi M, López-Cabrera M, Strippoli R. Terri M, et al. Among authors: rosano l. J Exp Clin Cancer Res. 2024 Jan 23;43(1):27. doi: 10.1186/s13046-023-02930-8. J Exp Clin Cancer Res. 2024. PMID: 38254102 Free PMC article.
Editorial: Women in molecular and cellular oncology.
Ferrao PT, Rosanò L, Poli V, Dhar SS, Lepique AP. Ferrao PT, et al. Among authors: rosano l. Front Oncol. 2023 Sep 4;13:1257780. doi: 10.3389/fonc.2023.1257780. eCollection 2023. Front Oncol. 2023. PMID: 37731644 Free PMC article. No abstract available.
A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas.
Díaz Méndez AB, Sacconi A, Tremante E, Lulli V, Caprara V, Rosanò L, Goeman F, Carosi M, Di Giuliani M, Vari G, Silvani A, Pollo B, Garufi C, Ramponi S, Simonetti G, Ciusani E, Mandoj C, Scalera S, Villani V, Po A, Ferretti E, Regazzo G, Rizzo MG. Díaz Méndez AB, et al. Among authors: rosano l. J Exp Clin Cancer Res. 2023 Mar 17;42(1):66. doi: 10.1186/s13046-023-02639-8. J Exp Clin Cancer Res. 2023. PMID: 36932446 Free PMC article.
Bcl-2-like protein-10 increases aggressive features of melanoma cells.
Del Bufalo D, Di Martile M, Valentini E, Manni I, Masi I, D'Amore A, Filippini A, Nicoletti C, Zaccarini M, Cota C, Castro MV, Quezada MJ, Rosanò L, Lopez-Bergami P, D'Aguanno S. Del Bufalo D, et al. Among authors: rosano l. Explor Target Antitumor Ther. 2022;3(1):11-26. doi: 10.37349/etat.2022.00068. Epub 2022 Jan 30. Explor Target Antitumor Ther. 2022. PMID: 36046354 Free PMC article.
SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.
Loria R, Laquintana V, Scalera S, Fraioli R, Caprara V, Falcone I, Bazzichetto C, Di Martile M, Rosanò L, Del Bufalo D, Bossi G, Sperduti I, Terrenato I, Visca P, Soddu S, Milella M, Ciliberto G, Falcioni R, Ferraresi V, Bon G. Loria R, et al. Among authors: rosano l. J Exp Clin Cancer Res. 2022 Apr 19;41(1):148. doi: 10.1186/s13046-022-02354-w. J Exp Clin Cancer Res. 2022. PMID: 35440004 Free PMC article.
95 results